Daniel R. Brooks, DSc

Associate Professor, Epidemiology
Daniel Brooks
(617) 358-3975danbrook@bu.edu
Talbot – T320E
View full profile at BUMC

Biography

Dr. Brooks is also the Associate Chair for Education in the Department of Epidemiology, director of the MPH certificate in Chronic and Non-communicable Diseases, member of the Epidemiology Doctoral Committee, and the instructor for a doctoral-level seminar in issues of study design. Prior to joining the faculty at BUSPH, Dr. Brooks spent more than 10 years at the Massachusetts Department of Public Health, first as Research Director for the Occupational Health Surveillance Program and then as Director of the Health Survey Program, where he directed all aspects of the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS). Dr. Brooks has two primary areas of research focus: (1) He leads an international team of researchers investigating the causes of an epidemic of chronic kidney disease of undetermined etiology (CKDu) in Central America that primarily affects poorer male manual laborers and is responsible for an estimated 20,000 deaths over the past two decades (http://www.bu.edu/sph/research/research-landing-page/research-group-for-the-study-of-chronic-kidney-disease-in-central-america/). The research is informed by a lifecourse approach, focusing on occupational risks, early life exposures, and genetic susceptibility that might potentiate environmental exposures. Suspected environmental factors under investigation include heat stress and dehydration, agrichemicals, infectious agents, metals, and medications with potential for kidney toxicity. Dr. Brooks also is a member of the Executive Board of the Consortium on the Epidemic of Nephropathy in Central America and Mexico (CENCAM), an organization of researchers, clinicians, and public health professionals from more than a dozen countries whose mission is to contribute to knowledge generation and to promote and facilitate activities and policies to reduce CKDu occurrence in the affected countries. (2) A second area of research focuses on increasing cessation among low-income smokers, particularly residents of public housing. Dr. Brooks was principal investigator of a grant from the National Cancer Institute to conduct a group-randomized trial in Boston public housing developments to test whether use of specialized resident community health advocates could increase use of smoking cessation treatments and subsequent quit rates among smokers living in public housing. Results of the study indicated that this may be an effective strategy. Currently, his work in this area focuses particularly on the federal rule mandating smoke-free policies in public housing authorities throughout the country. Ongoing studies include (i) an intervention funded by the Department of Housing and Urban Development (HUD) to increase resident support and compliance with a smoke-free policy in a privately managed affordable housing setting and (ii) a study co-funded by the Robert Wood Johnson Foundation and American Cancer Society to learn from the experiences of housing authorities that have already voluntarily adopted smoke-free policies in order to assist the large number of authorities who will be adopting policies as a result of the federal rule.

Education

  • Boston University, MPH
  • University of Michigan at Ann Arbor, BA
  • Boston University, DSc

Classes Taught

  • SPHPH780

Publications

  • Published on 1/1/2018

    Anthony J, Goldman R, Rees VW, Frounfelker RL, Davine J, Keske RR, Brooks DR, Geller AC. Qualitative Assessment of Smoke-Free Policy Implementation in Low-Income Housing: Enhancing Resident Compliance. Am J Health Promot. 2018 Jan 01; 890117118776090. PMID: 29772910.

    Read at: PubMed
  • Published on 11/14/2017

    Brooks DR, Burtner JL, Borrelli B, Heeren TC, Evans T, Davine JA, Greenbaum J, Scarpaci M, Kane J, Rees VW, Geller AC. Twelve-Month Outcomes of a Group-Randomized Community Health Advocate-Led Smoking Cessation Intervention in Public Housing. Nicotine Tob Res. 2017 Nov 14. PMID: 29145626.

    Read at: PubMed
  • Published on 11/10/2017

    Geller AC, Borrelli B, Davine JA, Burtner J, Heeren TC, Rees VW, Adekgoke A, Brooks DR. Factors associated with recent use of nicotine replacement therapy among multiethnic smokers residing in public housing. Journal of Smoking Cessation. 2017.

  • Published on 7/15/2017

    Ross CS, Brooks DR, Aschengrau A, Siegel MB, Weinberg J, Shrier LA. Positive and negative affect following marijuana use in naturalistic settings: An ecological momentary assessment study. Addict Behav. 2018 01; 76:61-67. PMID: 28756041.

    Read at: PubMed
  • Published on 2/17/2017

    Riefkohl A, Ramírez-Rubio O, Laws RL, McClean MD, Weiner DE, Kaufman JS, Galloway RL, Shadomy SV, Guerra M, Amador JJ, Sánchez JM, López-Pilarte D, Parikh CR, Leibler JH, Brooks DR. Leptospira seropositivity as a risk factor for Mesoamerican Nephropathy. Int J Occup Environ Health. 2017 Jan; 23(1):1-10. PMID: 28209095.

    Read at: PubMed
  • Published on 1/1/2017

    Brooks D, Crowe J, Lucas R. Mesoamerican Nephropathy: Report from the Second International Research Workshop on MeN (Wegman D, Crowe J, Hogstedt C, Jakobsson K, Wesseling C, eds.). Heat stress and dehydration. SALTRA/IRET-UNA. Heredia. 2017; 59-64.

  • Published on 1/1/2017

    McClean MD, Laws RL, Amador JJ, Lopez-Pilarte D, Scammell MK, Ramirez-Rubio O, Friedman DJ, Kaufman JS, Weiner DE, Riefkohl A, Brooks DR. Mesoamerican Nephropathy: Report from the Second International Research Workshop on MeN (Wegman D, Crowe J, Hogstedt C, Jakobsson K, Wesseling C, eds.). Boston University School of Public Health: Studies of occupational and non-occupational risk factors for chronic kidney disease. SALTRA/IRET-UNA. Heredia. 2017; 95-100.

  • Published on 10/3/2016

    Moses E, Wang T, Corbett S, Jackson GR, Drizik E, Perdomo C, Perdomo C, Kleerup E, Brooks D, O'Connor G, Dubinett S, Hayden P, Lenburg ME, Spira A. Molecular Impact of Electronic Cigarette Aerosol Exposure in Human Bronchial Epithelium. Toxicol Sci. 2017 Jan; 155(1):248-257. PMID: 27701119.

    Read at: PubMed
  • Published on 8/26/2016

    Kupferman J, Amador JJ, Lynch KE, Laws RL, López-Pilarte D, Ramírez-Rubio O, Kaufman JS, Lau JL, Weiner DE, Robles NV, Verma KP, Scammell MK, McClean MD, Brooks DR, Friedman DJ. Characterization of Mesoamerican Nephropathy in a Kidney Failure Hotspot in Nicaragua. Am J Kidney Dis. 2016 Nov; 68(5):716-725. PMID: 27575010.

    Read at: PubMed
  • Published on 8/26/2016

    García-Trabanino R, Jakobsson K, Guzmán Quilo C, Brooks DR, Crowe J, Barnoya J, Madero M, González Quiroz M, Wesseling C, Wegman DH, Correa-Rotter R. In reply to: "Should we consider renaming 'Mesoamerican Nephropathy' as Nephropathy of Unknown Cause in Agricultural Labourers (NUCAL)?" Occup Environ Med. 2016 Nov; 73(11):802-803. PMID: 27566784.

    Read at: PubMed

View 89 more publications:View full profile at BUMC

News & In the Media